KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Enterprise Value: 2009-2024

Historic Enterprise Value for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to $22.0 billion.

  • Teva Pharmaceutical Industries' Enterprise Value rose 20.43% to $21.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 billion, marking a year-over-year increase of 54.53%. This contributed to the annual value of $22.0 billion for FY2024, which is 141.98% up from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Enterprise Value stood at $22.0 billion for FY2024, which was up 141.98% from $9.1 billion recorded in FY2023.
  • Teva Pharmaceutical Industries' 5-year Enterprise Value high stood at $22.0 billion for FY2024, and its period low was $7.6 billion during FY2021.
  • Its 3-year average for Enterprise Value is $13.1 billion, with a median of $9.1 billion in 2023.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Enterprise Value fell by 19.06% in 2021 and then surged by 141.98% in 2024.
  • Yearly analysis of 5 years shows Teva Pharmaceutical Industries' Enterprise Value stood at $9.4 billion in 2020, then fell by 19.06% to $7.6 billion in 2021, then grew by 6.36% to $8.1 billion in 2022, then grew by 12.00% to $9.1 billion in 2023, then spiked by 141.98% to $22.0 billion in 2024.